CClinicalTrials.gg
CompletedNCT01660139Updated Nov 1, 2018

Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics

An observational study in Dermatologic Disorders, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-01.

Sponsored by Northwestern University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
75
Ages
18 Years and older
Sex
All
01

Study summary

This study is to assess the practice of complementary and alternative medicine (CAM) for skin related conditions among patients in the Primary Care and Dermatology clinics.

Read the detailed description

This study aims to determine the prevalence and characteristics complementary and alternative medicine (CAM) usage among Primary Care and Dermatology clinic patients through the use of an anonymous, self-completed written survey. This survey will assess the prevalence and regularity of CAM usage (with and without concurrent use of allopathic therapies), the reasons for CAM usage, perceived success with CAM usage, and socioeconomic status, in both Dermatology and Primary Care patients. We will then compare these elements of CAM usage between the two clinic patient populations.

02

Conditions studied

  • Dermatologic Disorders

Browse trials for

03

In context

Skin Diseases

538 studies on the registry are indexed under Skin Diseases; 92 are open to participants now.

This study's enrollment of 75 is below the median of 168 across 147 observational studies indexed under Skin Diseases.

Browse Skin Diseases studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients attending clinic appointments in dermatology and primary care clinics.

Inclusion criteria

  • 18 years or older
  • Presents for a clinic appointment with a dermatologist or primary care physician
  • English-speaking

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years or older
  • Non-English speaking
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
75 participants (actual)
Patient registry
No

Groups and cohorts

  • Dermatology Clinic Patients

    Patient attending dermatology clinics

  • Primary Clinic Patients

    Patient attending primary care clinics

06

What researchers measure

Primary outcomes

  1. Prevalence of complementary and alternative medicine usage among patients in the clinics

    At the clinic appointment, patients will be given a survey that asks about whether the patient uses complementary and alternative medicine for skin related issues.

    Time frame: 5 minutes to complete survey

Secondary outcomes

  1. Characteristics of the patients complementary and alternative medicine use

    Patients who practice complementary and alternative medicine will be asked about what and how they practice their complementary and alternative medicine.

    Time frame: 5 minutes to complete survey

07

Study locations

1 site
  • Northwestern University Department of Dermatology
    Chicago, Illinois 60611, United States
08

References and documents

Publications

  • Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005 Jan-Feb;11(1):42-9. PubMed 15712765 ↗
  • Parkman CA. CAM therapies and nursing competency. J Nurses Staff Dev. 2002 Mar-Apr;18(2):61-5; quiz 66-7. doi: 10.1097/00124645-200203000-00001. PubMed 11984258 ↗
  • Ernst E. The usage of complementary therapies by dermatological patients: a systematic review. Br J Dermatol. 2000 May;142(5):857-61. doi: 10.1046/j.1365-2133.2000.03463.x. PubMed 10809840 ↗
  • Ernst E, Pittler MH, Stevinson C. Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments. Am J Clin Dermatol. 2002;3(5):341-8. doi: 10.2165/00128071-200203050-00006. PubMed 12069640 ↗
  • Smith N, Shin DB, Brauer JA, Mao J, Gelfand JM. Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol. 2009 Mar;60(3):419-25. doi: 10.1016/j.jaad.2008.11.905. Epub 2009 Jan 20. PubMed 19157642 ↗
  • Fuhrmann T, Smith N, Tausk F. Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey. J Am Acad Dermatol. 2010 Dec;63(6):1000-5. doi: 10.1016/j.jaad.2009.12.009. Epub 2010 Oct 8. PubMed 20933300 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01660139
Lead sponsor
Northwestern University
Responsible party
Maria Colavincenzo (Assistant Professor, Department of Dermatology, Northwestern University) — Principal investigator
First posted
Aug 8, 2012
Start date
Jul 2012
Primary completion
Oct 2015
Completion
Oct 2015
Last update
Nov 1, 2018

Study contacts

Maria Colavincenzo, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion